期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 26, 期 20, 页码 -出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v26.i20.2514
关键词
Metabolomics; Nuclear magnetic resonance spectroscopy; Pancreatic cancer; Gastric cancer; Colorectal cancer; Biological fluids
资金
- Foundation Ente Cassa di Risparmio di Firenze [FCR 2017]
- Italian Ministry of Health, Ricerca Finalizzata 2016 [FR-2016-02361616]
Despite recent progress in diagnosis and therapy, gastrointestinal (GI) cancers remain one of the most important causes of death with a poor prognosis due to late diagnosis. Serum tumor markers and detection of occult blood in the stool are the current tests used in the clinic of GI cancers; however, these tests are not useful as diagnostic screening since they have low specificity and low sensitivity. Considering that one of the hallmarks of cancer is dysregulated metabolism and metabolomics is an optimal approach to illustrate the metabolic mechanisms that belong to living systems, is now clear that this -omics could open a new way to study cancer. In the last years, nuclear magnetic resonance (NMR) metabolomics has demonstrated to be an optimal approach for diseases' diagnosis nevertheless a few studies focus on the NMR capability to find new biomarkers for early diagnosis of GI cancers. For these reasons in this review, we will give an update on the status of NMR metabolomic studies for the diagnosis and development of GI cancers using biological fluids.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据